Exposures to antineoplastic antineoplastic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Tumor Cells, Cultured Cell Line, Tumor HL-60 Cells Cell Line Cells, Cultured HT29 Cells Lymphocytes K562 Cells Kidney

Organisms8

Narcissus Mice, Nude Aster Plant Olacaceae Mice, Inbred BALB C Mice, SCID Mice, Inbred DBA Mice, Inbred C57BL

Diseases32

Leukemia P388 Neoplasms Sarcoma 180 Leukemia L1210 Neoplasms, Experimental Lung Neoplasms Breast Neoplasms Colonic Neoplasms Leukemia Ovarian Neoplasms Prostatic Neoplasms Phlebitis Carcinoma, Ehrlich Tumor Lymphoma Mammary Neoplasms, Experimental Drug-Related Side Effects and Adverse Reactions Brain Neoplasms Adenocarcinoma Glioma Neovascularization, Pathologic Leukemia, Experimental Multiple Myeloma Colorectal Neoplasms Leukopenia Vomiting Melanoma Neoplasm Metastasis Nausea Bone Neoplasms Melanoma, Experimental Cardiomyopathies Kidney Neoplasms

Chemicals and Drugs127

Antineoplastic Agents Antineoplastic Agents, Phytogenic Amaryllidaceae Alkaloids Antibiotics, Antineoplastic Ellipticines Doxorubicin Bibenzyls Thiadiazines Antineoplastic Agents, Alkylating Bryostatins Gallium Ancitabine Cisplatin Depsipeptides Paclitaxel 6-Mercaptopurine Epothilones Antimetabolites, Antineoplastic Aminoacridines Lactones Daunorubicin Fluorouracil Bleomycin Etoposide Prodrugs Methotrexate Macrolides Camptothecin Enzyme Inhibitors Stilbenes Phospholipid Ethers Vincristine Cyclophosphamide Isoquinolines Caspases Taxoids Sulindac DNA RNA, Messenger Reactive Oxygen Species Amsacrine Vanadium Compounds Hazardous Substances Thiosemicarbazones Floxuridine 2-Propanol Carmustine Cytarabine Topoisomerase II Inhibitors Farnesyltranstransferase Drugs, Investigational Isocoumarins Nitrogen Mustard Compounds Dioxoles Suramin Alkaloids Plant Extracts Mitomycin Topoisomerase I Inhibitors Azacitidine DNA Adducts DNA Topoisomerases, Type II Anti-Inflammatory Agents, Non-Steroidal Nitrosourea Compounds Pyrones Pyrazines Hydrazones Sulfonamides DNA, Neoplasm Alkylating Agents Razoxane Phosphorylcholine Organoplatinum Compounds Octreotide Glutathione Transferase Lomustine Piperazines Mitomycins Dehydroascorbic Acid Anthracyclines P-Glycoprotein Intercalating Agents Benzoquinones Histone Deacetylase Inhibitors Topotecan Phenanthridines Vinblastine Diphosphonates Tetrahydroisoquinolines Caspase 3 Deoxycytidine Boronic Acids Glutathione Mitoxantrone Annexin A5 Drug Carriers Hydrazines Melphalan Proto-Oncogene Proteins c-bcl-2 Tubulin Modulators Thymidylate Synthase Anticarcinogenic Agents Angiogenesis Inhibitors Pyrroles Thiazoles Sesquiterpenes Neoplasm Proteins Ifosfamide DNA Topoisomerases, Type I Cyclooxygenase Inhibitors Hydroxamic Acids Antibodies, Monoclonal, Humanized Radiation-Sensitizing Agents Protein Kinase Inhibitors O(6)-Methylguanine-DNA Methyltransferase Peptides, Cyclic Organometallic Compounds Multidrug Resistance-Associated Proteins Pyridines Fatty Acid Synthases Proteasome Inhibitors Antibodies, Monoclonal Deoxyguanosine Dexamethasone Colchicine Dacarbazine Purines

Analytical, Diagnostic and Therapeutic Techniques and Equipment34

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Drug Evaluation, Preclinical Drug Evaluation Xenograft Model Antitumor Assays Neoplasms, Experimental Neoplasm Transplantation Drug Administration Schedule Gloves, Protective Clinical Trials as Topic Protective Devices Equipment and Supplies, Hospital Protective Clothing Inhibitory Concentration 50 Treatment Outcome Drug Compounding Antineoplastic Protocols Tumor Stem Cell Assay Comet Assay Lethal Dose 50 Mutagenicity Tests Blotting, Western Mammary Neoplasms, Experimental Flow Cytometry Transplantation, Heterologous Drug Carriers Transfection Leukemia, Experimental Drug Delivery Systems Tumor Burden Injections, Intraperitoneal Infusions, Intravenous Chromatography, High Pressure Liquid Melanoma, Experimental

Phenomena and Processes32

Apoptosis Drug Synergism Cell Survival Molecular Structure Dose-Response Relationship, Drug Drug Resistance, Neoplasm Cell Division Cell Cycle Drug Resistance Cell Proliferation DNA Damage Drug Interactions Biotransformation Time Factors Stereoisomerism Kinetics Structure-Activity Relationship Dental Physiological Processes Inhibitory Concentration 50 Drug Resistance, Multiple DNA Adducts Lethal Dose 50 Gene Expression Regulation, Neoplastic Metabolic Detoxication, Drug Cell Death Transfection Sister Chromatid Exchange Signal Transduction G2 Phase Phosphorylation Transcription, Genetic Tissue Distribution

Disciplines and Occupations2

Oncology Nursing Veterinary Medicine

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Information Science1

Molecular Sequence Data

Named Groups5

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses Pharmacists

Health Care18

Clinical Trials as Topic Occupational Exposure Medical Secretaries Oncology Nursing Equipment Contamination Decontamination Nursing Staff, Hospital Environmental Monitoring Treatment Outcome Personnel, Hospital Antineoplastic Protocols Pharmacies Oncology Service, Hospital Nurses Hospitals Pharmacists Cancer Care Facilities Safety Management

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Named Groups Health Care

Antineoplastic Agents Antineoplastic Agents, Phytogenic Leukemia P388 Amaryllidaceae Alkaloids Antibiotics, Antineoplastic Ellipticines Narcissus Drug Screening Assays, Antitumor Doxorubicin Bibenzyls Thiadiazines Antineoplastic Agents, Alkylating Bryostatins Neoplasms Gallium Tumor Cells, Cultured Ancitabine Cisplatin Depsipeptides Apoptosis Paclitaxel Drug Synergism Cell Line, Tumor 6-Mercaptopurine Cell Survival Epothilones Antimetabolites, Antineoplastic Aminoacridines Sarcoma 180 Molecular Structure Leukemia L1210 Lactones Antineoplastic Combined Chemotherapy Protocols Daunorubicin Dose-Response Relationship, Drug Fluorouracil Bleomycin Drug Resistance, Neoplasm Etoposide Drug Evaluation, Preclinical Cell Division Drug Evaluation Xenograft Model Antitumor Assays Prodrugs Neoplasms, Experimental Methotrexate Cell Cycle Macrolides Drug Resistance Cell Proliferation HL-60 Cells Camptothecin Mice, Nude Enzyme Inhibitors Stilbenes Lung Neoplasms Phospholipid Ethers Neoplasm Transplantation Drug Administration Schedule Vincristine Cyclophosphamide Gloves, Protective DNA Damage Breast Neoplasms Drug Interactions Isoquinolines Biotransformation Time Factors Clinical Trials as Topic Aster Plant Cell Line Colonic Neoplasms Leukemia Ovarian Neoplasms Stereoisomerism Kinetics Occupational Exposure Olacaceae Caspases Prostatic Neoplasms Taxoids Medical Secretaries Oncology Nursing Structure-Activity Relationship Laundering Sulindac Protective Devices DNA Dental Physiological Processes RNA, Messenger Equipment and Supplies, Hospital Protective Clothing Cells, Cultured Equipment Contamination Reactive Oxygen Species Amsacrine Decontamination Vanadium Compounds Phlebitis Nursing Staff, Hospital

No FAQ available that match "exposures to antineoplastic antineoplastic agents"